Factor Therapeutics Ltd (FTT)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Factor Therapeutics Ltd (FTT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011683
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor which is being developed to treat venous leg ulcers. FTL offers cell culture reagents to enhance the growth of mammalian cells for cell-based therapies. The company’s VF-001 pursues the development of other product candidates which may be applicability to other wound care applications. It utilizes third parties for development and commercialization of its novel products. FTL is headquartered in Brisbane, Queensland, Australia.

Factor Therapeutics Ltd (FTT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Factor Therapeutics Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Factor Therapeutics Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Factor Therapeutics Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Factor Therapeutics Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Factor Therapeutics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Factor Therapeutics Ltd, Medical Equipment, Deal Details 10
Equity Offering 10
Tissue Therapies Completes Rights Offering Of Shares For US$4.5 Million 10
Tissue Therapies Announces Private Placement Of Shares For US$0.5 Million 12
Tissue Therapies Completes Private Placement Of Shares For US$3 Million 13
Tissue Therapies Announces Private Placement Of Shares For US$1.2 Million 15
Factor Therapeutics Ltd – Key Competitors 16
Factor Therapeutics Ltd – Key Employees 17
Factor Therapeutics Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Aug 03, 2016: Factor Therapeutics: Formation of Medical Advisory Board 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Factor Therapeutics Ltd, Medical Equipment, Key Facts, 2017 2
Factor Therapeutics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Factor Therapeutics Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Factor Therapeutics Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Factor Therapeutics Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Factor Therapeutics Ltd, Deals By Market, 2011 to YTD 2017 8
Factor Therapeutics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Tissue Therapies Completes Rights Offering Of Shares For US$4.5 Million 10
Tissue Therapies Announces Private Placement Of Shares For US$0.5 Million 12
Tissue Therapies Completes Private Placement Of Shares For US$3 Million 13
Tissue Therapies Announces Private Placement Of Shares For US$1.2 Million 15
Factor Therapeutics Ltd, Key Competitors 16
Factor Therapeutics Ltd, Key Employees 17
Factor Therapeutics Ltd, Other Locations 18
Factor Therapeutics Ltd, Subsidiaries 18

★海外企業調査レポート[Factor Therapeutics Ltd (FTT)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Centra Industries, Inc.:企業の戦略・SWOT・財務情報
    Centra Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Centra Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Industrias Penoles SAB de CV:戦略・SWOT・企業財務分析
    Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Industrias Penoles SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • PT Rekayasa Industri:企業の戦略的SWOT分析
    PT Rekayasa Industri - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • TCR (London) Ltd :企業の戦略・SWOT・財務情報
    TCR (London) Ltd - Strategy, SWOT and Corporate Finance Report Summary TCR (London) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • EMCORE Corporation (EMKR)-エネルギー分野:企業M&A・提携分析
    Summary EMCORE Corporation (EMCORE) is a communication network infrastructure equipment company that provides optical components and end-to-end solutions. It designs and manufactures indium phosphide optical chips, components, subsystems, and systems. The company produces its products through linear …
  • JM AB:企業の戦略・SWOT・財務情報
    JM AB - Strategy, SWOT and Corporate Finance Report Summary JM AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • InflaRx NV (IFRX):製薬・医療:M&Aディール及び事業提携情報
    Summary InflaRx NV (InflaRx) is a clinical-stage biopharmaceutical company that develops therapies in the field of acute and chronic inflammation. The company offers development of monoclonal antibodies targeting activation products of the complement system for application in threatening inflammator …
  • Mechanics Bank:企業の戦略・SWOT・財務情報
    Mechanics Bank - Strategy, SWOT and Corporate Finance Report Summary Mechanics Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Lario Oil & Gas Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Lario Oil & Gas Co (Lario Oil & Gas) is an oil and gas exploration and production company that explores and produces oil and gas properties. The company offers services such as discovering reserves organically from geologic thesis, drill-bit, field delineation, and land acquisition and explo …
  • Nine Dragons Paper (Holdings) Ltd
    Nine Dragons Paper (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Nine Dragons Paper (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Pilot Energy Ltd (PGY):石油・ガス:M&Aディール及び事業提携情報
    Summary Pilot Energy Ltd (Pilot), formerly Rampart Energy Ltd is an oil and gas exploration and production company. The company acquires, explores and develops conventional oil and gas assets in Australia. Its projects include Australia EP416 and EP480, Australia WA-507-P, Australia WA-503-P and Aus …
  • eClinicalWorks LLC:企業の戦略的SWOT分析
    eClinicalWorks LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • GGP Inc:企業の戦略・SWOT・財務情報
    GGP Inc - Strategy, SWOT and Corporate Finance Report Summary GGP Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Abcam Plc (ABC)-医療機器分野:企業M&A・提携分析
    Summary Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondar …
  • Immatics Biotechnologies GmbH:企業のM&A・事業提携・投資動向
    Immatics Biotechnologies GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Immatics Biotechnologies GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Novanta Inc (NOVT)-医療機器分野:企業M&A・提携分析
    Summary Novanta Inc (Novanta), formerly GSI Group Inc. is a medical device company that manufactures and markets precision photonics, motion control components and subsystems. The company provides laser products, medical technologies, and precision motion products. It offers laser sources and beam d …
  • Visteon Corporation:企業のM&A・事業提携・投資動向
    Visteon Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Visteon Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Clark Public Utilities:企業の戦略的SWOT分析
    Clark Public Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Evoke Pharma Inc (EVOK):企業の財務・戦略的SWOT分析
    Summary Evoke Pharma Inc (Evoke Pharma) is a pharmaceutical company that develops drugs to treat gastrointestinal diseases (GI). The company offers Gimoti that provides predictable absorption and symptom relief during a flare regardless of gastric emptying delays and vomiting. Evoke Pharma also offe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆